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The NIb protein of tobacco etch potyvirus (TEV) possesses several functions, including RNA-dependent RNA
polymerase and nuclear translocation activities. Using a reporter protein fusion strategy, NIb was shown to
contain two independent nuclear localization signals (NLS I and NLS II). NLS I was mapped to a sequence
within amino acid residues 1 to 17, and NLS II was identified between residues 292 and 316. Clustered point
mutations resulting in substitutions of basic residues within the NLSs were shown previously to disrupt
nuclear translocation activity. These mutations also abolished TEV RNA amplification when introduced into
the viral genome. The amplification defects caused by each NLS mutation were complemented in trans within
transgenic cells expressing functional NIb, although the level of complementation detected for each mutant
differed significantly. Combined with previous results (X. H. Li and J. C. Carrington, Proc. Natl. Acad. Sci.
USA 92:457–461, 1995), these data suggest that the NLSs overlap with essential regions necessary for NIb
trans-active function(s). The fact that NIb functions in trans implies that it must interact with one or more other
components of the genome replication apparatus. A yeast two-hybrid system was used to investigate physical
interactions between NIb and several other TEV replication proteins, including the multifunctional VPg/
proteinase NIa and the RNA helicase CI. A specific interaction was detected between NIa and NIb. Deletion of
any of five regions spanning the NIb sequence resulted in NIb variants that were unable to interact with NIa.
Clustered point mutations affecting the conserved GDD motif or NLS II within the central region of NIb, but
not mutations affecting NLS I near the N terminus, reduced or eliminated the interaction. The C-terminal
proteinase (Pro) domain of NIa, but not the N-terminal VPg domain, interacted with NIb. The effects of NIb
mutations within NLS I, NLS II, and the GDD motif on the interaction between the Pro domain and NIb were
identical to the effects of these mutations on the interaction between full-length NIa and NIb. These data are
compatible with a model in which NIb is directed to replication complexes through an interaction with the Pro
domain of NIa.
The biochemical mechanisms involved in replication of ge-
nomes of positive-strand RNA viruses of eukaryotes are un-
derstood poorly. This statement is particularly applicable to
members of the picornavirus supergroup. In large part, this is
due to difficulties in reconstituting the complete picornavirus-
like viral replicative cycle in vitro by using purified replication
factors (53). A complete picture of how viral- and host-en-
coded factors and structures are coordinated during replica-
tion complex formation and RNA synthesis, therefore, has yet
to emerge.
Tobacco etch potyvirus (TEV) is a well-characterized mem-
ber of the Potyviridae. This family shares genome organiza-
tional features with other families within the picornavirus su-
pergroup (32). The TEV genome is covalently attached to a
virus-encoded protein, termed VPg, and encodes a large
polyprotein of 346 kDa (1). At least nine mature proteins arise
by proteolytic processing catalyzed by three TEV-encoded pro-
teinases (16) (see Fig. 1A). Several proteins derived from the
central region of the viral polyprotein, in the order CI-6K-NIa-
NIb, are proposed to function directly in RNA replication. The
CI protein contains nucleoside triphosphatase and RNA un-
winding activities and exhibits sequence similarity with several
known RNA helicases (34, 35). The 6-kDa protein is associated
tightly with membranes and may serve to anchor RNA repli-
cation complexes to membranous sites of synthesis (46). The
multifunctional NIa protein contains a VPg domain within the
N-terminal half and a picornavirus 3C-like proteinase (Pro)
domain proximal to the C terminus (8, 50). The NIb protein
likely functions as the RNA-dependent RNA polymerase (1,
14). The CI-6K-NIa-NIb region of the polyprotein contains
sequence and functional similarity with the 2C-3A-3B-3C-3D
region of the picornavirus polyprotein (32, 53).
The NIa proteinase is required for proteolytic maturation of
the majority of viral proteins (6–8, 20, 25). This enzyme exhib-
its cis-preferential proteolytic activity in vitro at several sites,
including the CI/6K, 6K/NIa, and NIa/NIb cleavage sites, and
trans-proteolytic activity at the P3-CI and NIb-capsid protein
sites. Additionally, NIa catalyzes cleavage at an internal site
between the VPg and Pro domains (15). Processing at the NIa
internal site is extremely inefficient due to a suboptimal cleav-
age site motif flanking the scissile bond. Internal cleavage
site-inactivating mutations, as well as mutations resulting in
accelerated internal cleavage, are amplification debilitated (11,
49), suggesting that the slow processing characteristic of the
internal site is an important regulatory feature. Both full-
length NIa and the processed N-terminal domain have been
detected as VPg molecules covalently bound to genomic RNA
(11, 40).
Despite the requirement for NIa and NIb in the cytoplasm
or membrane-bound replication complexes during proteolytic
processing and viral RNA synthesis, the vast majority of NIa
and NIb molecules are localized in the nucleus of infected cells












(5, 44). Both proteins contain independent nuclear localization
signals (NLSs) (10, 37, 44). Localization of at least a subset of
NIa and NIb molecules to membranous sites of replication was
proposed to occur by at least two mechanisms. The NIa protein
or VPg domain may be directed toward replication complexes
through covalent association with the 6K protein in a polypro-
tein form. The membrane-binding activity of the 6K protein is
sufficient to override the nuclear localization activity of NIa
(45). By genetic complementation analysis, the NIb protein
was shown to be a trans-active protein that can be supplied
from outside the context of the TEV polyprotein (36). There-
fore, NIb may be recruited to replication complexes through
protein-protein interactions with other viral or host factors or
by protein-RNA interactions (26, 36).
To investigate further the activities of NIb, nuclear transport
requirements and interactions with other TEV-encoded pro-
tein were analyzed. Two independent NLSs were identified by
using a reporter protein fusion approach. In addition, a com-
binatorial study of TEV protein-protein interactions by using
the yeast two-hybrid system revealed that NIb interacted spe-
cifically with the Pro domain of NIa.
MATERIALS AND METHODS
Plasmid construction. Vectors containing regulatory sequences and coding
regions for plant transformation were generated with pGA482 (2). pGA-GUS/
NIb contains the sequence encoding a fusion protein consisting of b-glucuroni-
dase (GUS) and NIb, while pGA-GUS contains the nonfused GUS coding
sequence (37, 44). pGA-G/b.1-17 and pGA-G/b.292-316 contain the GUS se-
quence fused to the 59 end of a cDNA fragment coding for either amino acids 1
to 17 or 292 to 316 of NIb, respectively.
As described previously, pTEV7DAN-GUS contains a full-length cDNA of
the TEV genome with the GUS sequence inserted between the P1 and HC-Pro
coding regions (12, 13). Clustered point mutations resulting in substitutions of
Glu-Asp-Glu for Lys3-Arg4-Lys5 (EDE mutation), Asp-Asp for Lys303-Lys304
(DD mutation), and Val-Asn-Asn for Gly357-Asp348-Asp349 (VNN mutation)
within the NIb sequence of pTEV7DAN-GUS were described elsewhere (36,
37).
Two shuttle plasmids, pAS2 and pACT2 (obtained from Stephen Elledge),
containing the coding sequences for the GAL4 DNA-binding domain (DB) or
transcriptional activation domain (ACT), respectively, were used for all yeast
two-hybrid experiments (17, 18). Sequences coding for NIa, NIb, CI, or GUS
were inserted into pAS2 at the 39 end of the DB region, generating pAS.a, pAS.b,
pAS.CI, or pAS.G, respectively. The same sequences were also inserted into
pACT2 at the 39 end of the ACT region, resulting in pACT.a, pACT.b, pACT.CI,
or pACT.G, respectively. Sequences coding for the VPg domain (NIa codons 1
to 188) and Pro domain (NIa codons 189 to 430) were also subcloned into the
two vectors, yielding pACT.VPg, pACT.Pro, pAS.VPg, and pAS.Pro.
The EDE, DD, and VNN mutations were introduced into the NIb coding
sequence of pAS.b, resulting in pAS.EDE, pAS.DD, and pAS.VNN, respectively.
Five deletions were prepared by oligonucleotide-directed loop-out mutagenesis
(33). The sequences deleted were those for NIb codons 1 to 141 (bD1 mutation),
142 to 243 (bD2), 244 to 354 (bD3), 355 to 412 (bD4), and 413 to 512 (bD5). All
deletions and modifications were confirmed by DNA sequence analysis.
Two plasmids, pSE1111 derived from pACT and pSE1112 derived from pAS1
(obtained from Stephen Elledge), encoded fusions with the yeast proteins SNF4
and SNF1, respectively. These proteins are known to interact in the yeast two-
hybrid system (18) and were used as positive controls in several experiments. In
all two-hybrid experiments, cells doubly transformed with the parental plasmids,
pACT2 and pAS2, were analyzed in parallel with experimental samples.
Transgenic tobacco plants and subcellular localization of GUS activity. Trans-
genic plants expressing NIb (NIb1), GUS, or GUS/NIb fusion protein were
described previously (36, 37). Nicotiana tabacum cv. Xanthi nc and Havana425
plants were transformed with pGA-G/b.1-17 and pGA-G/b.292-316 as described
(9). Plant extracts were subjected to immunoblot analysis with anti-GUS serum
(37). The distribution of GUS activity in leaf epidermal cells of original trans-
formed plants and R1 progeny plants was analyzed with the histochemical GUS
substrate, X-Gluc (5-bromo-4-chloro-3-indolyl-b-D-glucuronic acid), as de-
scribed (44).
In vitro synthesis of transcripts and inoculation of protoplasts and plants.
Capped transcripts were synthesized with SP6 RNA polymerase (Ambion) as
described (13). Protoplasts from leaves of either vector-transformed or NIb1-
expressing plants were inoculated with transcripts as detailed previously (36).
GUS activity was analyzed in protoplasts 24, 48, and 72 h postinoculation (p.i.)
(11). Transgenic NIb1 or vector-transformed plants were also inoculated with
transcripts. Systemically infected tissue was harvested as soon as symptoms
developed (5 to 8 days p.i.) and ground in 5 volumes of 10 mM Tris-HCl–1 mM
EDTA, pH 7.6. The extracts were used to inoculate vector- or NIb1-transformed
plants. Histochemical GUS activity assays were conducted with inoculated leaves
at 3 days p.i.
Bacterial strains, yeast strains, and yeast transformation. Escherichia coli
TG1 and DH5a and Saccharomyces cerevisiae Y190 [MATa gal4 gal80 his3 trp1-901
ade2-101 ura3-52 leu2-3,-112/1URA3::GAL3lacZ LYS2::GAL(UAS)3HIS3 cyhr]
were used for all DNA cloning and expression. For yeast transformation, Y190
cells were grown at 308C in YEPD liquid medium (1% yeast extract–2% pep-
tone–2% glucose) to approximately 3 3 107 cells/ml, collected by centrifugation,
washed with TE buffer (10 mM Tris-HCl [pH 7.6], 1 mM EDTA), and resus-
pended in TE at a density of 0.5 3 109 to 1.0 3 109 cells/ml. An equal volume
of 0.2% LiCl was added to the cell suspension, and the mixture was incubated for
1 h at 308C. Approximately 1 mg of plasmid DNA/150 mg of salmon testes carrier
DNA (Sigma)/120 ml of 70% polyethylene glycol (molecular weight, 4,000; Fluka
Chemika) was mixed with 100 ml of TE-LiCl cell suspension and incubated for 2
to 4 h at 308C. After a 10-min heat shock at 428C, 1 ml of TE was mixed with the
transformation solution. Cells were sedimented by centrifugation for 1 min at
2,0003 g, resuspended in 100 ml of TE, and spread on 2% glucose-containing SC
medium lacking leucine (SC-Leu) for pACT2-derived plasmids or lacking tryp-
tophan (SC-Trp) for pAS2-derived plasmids. Cells from transformed colonies
were then transformed with a second, counterpart plasmid by the same proce-
dure as above, except that the cells were propagated in liquid SC-Leu or SC-Trp
medium before transformation and plated on SC-Leu-Trp double selective me-
dium after transformation. Transformed yeast cells were screened by immuno-
blot analysis using antisera against the respective TEV or control proteins or by
PCR analysis with TEV- or plasmid-specific primers.
In some experiments, the pAS2-derived plasmid from doubly transformed cells
was selectively removed. The Y190 strain is resistant to cycloheximide because of
a recessive mutation in the CYH2 gene. pAS2 contains a wild-type copy of the
CYH2 gene, rendering cells containing pAS-derived plasmids susceptible to cy-
cloheximide. Colonies of doubly transformed cells were streaked onto SC-Leu
medium containing 2.5 mg of cycloheximide/ml. Individual colonies were then
streaked onto SC-Leu and SC-Leu-Trp plates. Only those colonies that were able
to grow on SC-Leu plates and unable to grow on SC-Leu-Trp plates were used
further. These cells were then retransformed with a series of pAS2-derived
plasmids.
Filter and plate assays for b-galactosidase and His autotrophy. b-Galactosi-
dase (b-Gal) expression in yeast was tested initially by using a filter assay. Cells
were streaked onto SC-Leu-Trp medium containing 5% glycerol–2% lactic acid–
0.05% glucose and were incubated for 2 to 4 days at 308C. The colonies were then
transferred to a nitrocellulose membrane which was then immersed into liquid
nitrogen for at least 10 s. The membrane was placed on a Whatman no. 1 filter
paper soaked with 0.3 ml/square inch of Z buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM b-mercaptoethanol, pH 7.0)
containing 1 mg of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal;
Sigma B-4252)/ml and incubated at 308C for 2 to 14 h.
A growth assay on plates was used initially to score His autotrophy. Cells were
streaked onto SC-His medium containing 5% glycerol–2% lactic acid–0.05%
glucose and 25 mM 3-amino-1,2,4-triazole (3-AT; Sigma A8056) and incubated
at 308C for 4 to 8 days.
Quantitation of b-Gal activity. Yeast cells were grown to saturation in liquid
SC-Leu-Trp medium including 5% glycerol–2% lactic acid–0.05% glucose and
were subcultured in fresh medium with vigorous shaking at 308C to a density of
33 107 to 53 107 cells/ml. One milliliter of cells was harvested by centrifugation,
resuspended in 200 ml of Z buffer, and permeabilized by vigorous vortexing (6
pulses for 20 s) with 0.15 g of acid-treated glass beads (425 to 600 mm; Sigma
G-9268). Cellular debris and glass beads were removed by centrifugation, and 50
ml of the supernatant was diluted in 950 ml of Z buffer. The b-Gal reaction was
carried out by adding 200 ml of 4-mg/ml o-nitrophenyl b-D-galactopyranoside
(ONPG; Sigma N-1127) in 0.1 M potassium phosphate (pH 7) and incubating at
308C for 30 min. The reaction was stopped by adding 500 ml of 1 M Na2CO3 and
was further diluted by adding 1 ml of deionized H2O. Optical density (OD) was
measured at a 420-nm wavelength. Total protein was measured in each extract by
using the Bio-Rad protein assay dye according to the manufacturer. b-Gal
activity units (nanomoles of o-nitrophenol per minute per milligram of protein)
were calculated as follows: OD420 z v/k z t z p, where v is the total volume, t is the
reaction time (min), p is total protein (mg) in 50 ml of lysate, and k (50.0045) is
the OD of 1-nmol/ml o-nitrophenol at a 420-nm wavelength measured by using
a 10-mm light path (38).
Quantitative growth assay in SC-His medium. To quantify cell growth in the
absence of His, 15 ml of cells derived from the same saturated cultures used for
b-Gal quantitation was transferred to 3 ml of SC-His containing 5% glycerol–2%
lactic acid–0.05% glucose and 50 mM 3-AT. The cultures were incubated with
vigorous shaking at 308C for 2 to 3 days, depending on the experiment, and OD
was measured at a 600-nm wavelength. Adjusted OD600 was calculated as fol-
lows: OD600 of individual transformant 2 OD600 of the control pACT2:pAS2
transformant.











NIb contains two independent NLSs. The NIb protein con-
tains two short, basic regions (Lys3-Arg4-Lys5 and Lys303-
Lys304-His305-Lys306), a feature shared by most known NLSs
of plants and animals (21, 23, 43, 48). Substitution of these
residues abolished nuclear transport of a fusion protein con-
taining NIb and GUS in transgenic plants (37). However, the
specific role of these sequences in nuclear transport was not
clear, as substitutions of residues at several other positions also
eliminated transport activity. To test the hypothesis that these
basic regions function as NLSs, fusion proteins containing
GUS and NIb residues 1 to 17 or 292 to 316 (Fig. 1A) were
expressed and localized in transgenic plants transformed with
pGA.G/b.1-17 and pGA.G/b.292-316, respectively. As controls,
plants transformed with pGA482 (vector alone), pGA.GUS
encoding nonfused GUS, and pGA.GUS/NIb encoding the
GUS/NIb fusion protein were analyzed in parallel. Immuno-
blot analysis was conducted with transgenic leaf extracts using
anti-GUS serum. Proteins of approximately 126 kDa and 68
kDa were detected in plants transformed with pGA.GUS/NIb
and pGA.GUS, respectively (Fig. 1B, lanes 2 and 3). A con-
sistent feature of all pGA.GUS/NIb-transformed plants was
the relatively low level of accumulation of the GUS/NIb fusion
protein (Fig. 1B, lane 2), as was noted previously (37). The
basis for the low accumulation levels was not investigated fur-
ther. Immunoreactive proteins that migrated slightly slower
than GUS were detected in plants transformed with pGA.G/
b.1-17 and pGA.G/b.292-316 (lanes 5 and 6). No immunore-
active proteins were detected in plants transformed with the
vector alone (lane 1).
The subcellular localization properties of GUS and GUS
fusion proteins were investigated in epidermal cells from
leaves of transgenic plants by using the histochemical substrate
X-Gluc. No GUS activity was detected in plants transformed
with vector alone (Fig. 2). GUS activity was dispersed in the
cytoplasm of GUS-expressing cells, whereas the activity in the
GUS/NIb-expressing cells was detected predominantly in the
nucleus. In cells expressing the GUS/b.1-17 and GUS/b.292-
316 proteins, GUS activity was localized primarily to the nu-
cleus, although in some cells a low level of GUS activity was
detected in the cytoplasm (Fig. 2). These data indicate that two
regions of NIb, comprising residues 1 to 17 and 292 to 316,
contain functional NLSs (NLS I and NLS II, respectively).
Amplification and complementation of NIb transport-defec-
tive TEV mutants in protoplasts and plants. A mutation re-
sulting in the substitution of Asp-Asp for Lys303-Lys304 (DD
mutation) was introduced into the TEV-GUS genome. Muta-
tions resulting in substitutions of Glu-Asp-Glu for Lys3-Arg4-
Lys5 (EDE mutation) within NLS I and Val-Asn-Asn for the
conserved motif Gly347-Asp348-Asp349 (VNN mutation)
were placed in the TEV-GUS genome previously and shown to
debilitate RNA amplification (36). The VNN mutant, but not
the EDE mutant, was shown to be complemented relatively
efficiently by NIb supplied in trans by transgenic cells (36). The
amplification and complementation properties of the DD mu-
tant in protoplasts and plants were analyzed in parallel with
parental TEV-GUS and the EDE and VNN mutants. Proto-
plasts from vector transgenic or NIb1 transgenic plants were
inoculated with transcripts representing each genome, and
GUS activity at 24, 48, and 72 h p.i. was measured as a surro-
gate marker for viral RNA amplification over time. This ex-
periment was repeated three times with protoplasts prepared
from independent transgenic plants. Similar to the VNN and
EDE mutants, the DD mutant was unable to amplify in vector-
transformed protoplasts (Fig. 3, left panels). In NIb1 proto-
plasts, however, the DD mutant was amplified to a level com-
parable to that of the VNN mutant (Fig. 3, right panels). At
48 h p.i., GUS activity in DD mutant- and VNN mutant-
infected NIb1 cells reached 38.3%6 6.6% and 24.8%6 6.0%,
respectively, of the level of activity in parental TEV-GUS-
infected cells. Activity in the EDE mutant-infected NIb1 cells
reached a relative level of only 1.8% 6 0.7% compared to that
in parental virus-infected cells. The differential complementa-
tion levels of the DD and EDE mutants suggest that, although
both NLS I and NLS II overlap with regions essential for NIb
FIG. 1. Genetic map of the TEV genome and immunoblot analysis of trans-
genic plants. (A) Map of the TEV genome with the coding regions for individual
proteins indicated above. Vertical lines indicate positions coding for proteolytic
cleavage sites. The region representing NIb is enlarged below the genetic map.
The sequences encompassing NLS I (residues 1 to 17) and NLS II (292 to 316)
are indicated by the boxes on the enlargement and presented in single-letter
code. (B) Total protein was extracted from leaves of transgenic tobacco plants
and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and immunoblot analysis with anti-GUS serum. Samples in lanes
1 to 3 and lanes 4 to 6 were analyzed in two separate blots, which is why the
GUS-containing extract is shown in both lanes 3 and 4. The calculated molecular
masses for GUS (68 kDa), GUS/NIb fusion protein (126 kDa), and fusion
protein containing GUS and residues 1 to 17 of NIb (G/b.1-17) (70 kDa) are
indicated at the left.










activity, the functions disrupted by the NLS mutations may be
distinct.
Transgenic NIb1 plants, but not vector-transformed plants,
inoculated with the VNN, EDE, and DD mutant transcripts
exhibited symptoms similar to those induced by parental TEV-
GUS in upper, noninoculated leaves. Extracts from these in-
fected plants were used to inoculate several leaves in each of
three vector-transformed and NIb1 transgenic plants, and in-
oculated leaves were infiltrated with X-Gluc at 3 days p.i.
Infection foci (between 50 to 200 per leaf) and systemic symp-
toms were detected in NIb1 transgenic plants but not in vec-
tor-transformed plants (data not shown), confirming that the
virus produced in transgenic cells was the result of actual
trans-complementation rather than reversion or recombination
with the transgene.
NIb interacts specifically with NIa. The fact that NIb-defec-
tive mutants can be rescued by mature NIb from transgenic
cells indicates that this protein can function in trans. Recruit-
ment of NIb to replication complexes likely involves interac-
tions with other viral replication proteins, host factors, or viral
RNA. To test the hypothesis that NIb interacts with other TEV
replication proteins with catalytic functions in genome repli-
cation, a combinatorial two-hybrid system was used. Viral pro-
teins were expressed in yeast Y190 cells as fusion proteins
containing either GAL4 ACT or DB (17). The nomenclature
of each strain provides the code for the TEV or control protein
fused to ACT, a colon, and then the code for the protein fused
to DB. Protein-protein interaction was assayed by GAL4-me-
diated activation of lacZ and HIS3 reporter genes. Activation
was first tested by a b-Gal filter assay and growth on His-
lacking (SC-His) solid medium and then by quantitative b-Gal
and His-independent growth assays using liquid cultures. For a
positive control, a strain designated S4:S1, which expresses
fusion proteins containing the yeast SNF1 and SNF4 proteins
and which are known to interact (18), was used. For negative
controls, cells transformed with the two parental vectors en-
coding nonfused ACT and DB (v:v strain) or cells expressing a
TEV fusion protein and fusions containing either GUS, SNF1,
or SNF4 were used. Most combinations of fusion proteins
tested are listed in Tables 1 and 2.
FIG. 2. In situ localization of GUS activity on leaf epidermal cells of transgenic tobacco plants. Plants were transformed with empty vector (Vector) or with plasmids
encoding GUS, GUS/NIb fusion protein, or fusion proteins containing GUS and NIb residues 1 to 17 (G/b.1-17) or 292 to 316 (G/b.292-316.) b-Gluc activity was
detected by incubation of epidermal cells in the colorimetric substrate X-Gluc. Bar 5 20 mm.










In b-Gal filter assays, all strains expressing both NIa and NIb
(a:b or b:a) turned dark blue within 30 min, as did the S4:S1
positive control strain (Table 1 and Fig. 4B). The a:S1, S4:a,
and v:v strains failed to exhibit activity. Similarly, the a:b, b:a,
and S4:S1 control strains grew on SC-His solid medium,
whereas growth of the a:S1, S4:a, and v:v strains was dependent
on exogenous His (Fig. 4C). To confirm that b-Gal activation
and His autotrophy of the a:b and b:a strains were the result of
a specific interaction between NIa and NIb, the pAS2-derived
plasmid was depleted from both strains. Strains in which the
pAS2-based plasmid was depleted were given either a Da or Db
designation, depending on the specific plasmid depleted. These
strains were then retransformed with a series of pAS2-derived
plasmids encoding DB fusions with SNF1, GUS, NIa, or NIb.
Only the retransformed strains containing both NIa and NIb
fusions (a:Db1b and b:Da1a) exhibited b-Gal activity in the
filter assay and growth on SC-His plates (Table 1 and Fig. 4B
and C).
Quantitative assays for b-Gal activity and His autotrophy
were conducted with this initial series of strains, as well as with
all subsequent series of strains, using liquid cultures. At least
three independent double transformants were tested for most
two-hybrid combinations. Evidence for a positive interaction
was considered good if relatively high b-Gal activity and
growth in SC-His medium were evident for each of the three
individual transformants. Cells expressing both NIa and NIb
hybrid proteins (a:b, b:a, a:Db1b, and b:Da1a), as well as the
control SNF4 and SNF1 hybrid proteins (S4:S1), expressed
relatively high levels of b-Gal activity (Fig. 5A) and grew well
in SC-His medium (Fig. 5B). b-Gal activity was approximately
threefold higher on average in cells expressing NIa fused to
ACT and NIb fused to DB than in cells expressing the recip-
rocal hybrids. Although b-Gal activity in each transformant
containing the NIa and NIb fusion proteins was consistently
high, some variation was observed. Generally, differences be-
tween individual transformants were less than twofold in a
given experiment, but in a few cases this variation was as high
as fourfold. Combinations involving non-TEV proteins and
NIa or NIb (a:S1, a:Db1G, a:Db1S1, S4:a, b:Da1S1, and
b:Da1G) yielded b-Gal activity that was 100- to 1,000-fold
lower than the corresponding a:b or b:a strains (Fig. 5A), and
growth in SC-His medium was poor (Fig. 5B). Similarly, in
strains expressing fusions to detect self-interactions of NIa and
NIb (a:a and b:Da1b), no b-Gal activity above background was
detected, and growth in SC-His was poor (Table 1 and Fig. 5).
The physiological role for the CI helicase in TEV genome
replication is not clear, but it presumably interacts with viral
RNA and other replication proteins during initiation and/or
FIG. 3. Complementation of NIb-defective TEV-GUS mutants in NIb1
transgenic protoplasts. Transcripts corresponding to parental TEV-GUS or the
VNN, EDE, and DD mutants were used to inoculate vector transgenic (left
panels) or NIb1 transgenic (right panels) protoplasts. GUS activity was mea-
sured from samples taken at 24, 48, and 72 h p.i. Each datum point represents the
mean GUS value from two contemporaneous transfections. Data from three
independent experiments with different protoplast preparations are shown. Note
that independent protoplast preparations isolated from the same line in the
independent experiments often differed in absolute susceptibility but that the
relative amplification levels of parental TEV-GUS and each given mutant virus
were reproducible.
TABLE 1. Yeast strains, fusion combinations,
and b-Gal filter assays
Yeast
strain ACT fusion DB fusion
b-Gal filter
assaya
v:v Vector alone Vector alone 2
S4:S1 SNF4 SNF1 111
a:a NIa NIa 2
a:b NIa NIb 111
a:CI NIa CI 2
a:S1 NIa SNF1 1/2
a:Db1b NIa NIb (NIb depleted, NIb
added back)
111
a:Db1G NIa GUS (NIb depleted, GUS
added back)
2
a:Db1S1 NIa SNF1 (NIb depleted, SNF1
added back)
1/2
b:a NIb NIa 111
S4:a SNF4 NIa 2
CI:a CI NIa 2
b:Da1a NIb NIa (NIa depleted, NIa
added back)
111
b:Da1b NIb NIb (NIa depleted, NIb
added back)
2
b:Da1CI NIb CI (NIa depleted, CI
added back)
ND
b:Da1S1 NIb SNF1 (NIa depleted, SNF1
added back)
1/2
b:Da1G NIb GUS (NIb depleted, GUS
added back)
2
CI:b CI NIb 2
CI:G CI GUS 2
G:CI GUS CI 2
a Colorimetric b-Gal filter assays were conducted by using at least three in-
dependent transformants of each yeast strain. Reactions were scored as follows:
2, no visible reaction after overnight incubation; 1/2, weak, inconsistent reac-
tion that required overnight development; 111, strong reaction that developed
within 30 min; ND, not determined.










chain elongation reactions (47). The ability of the CI helicase
to interact with NIa or NIb in the two-hybrid assay was tested.
Reciprocal combinations were tested between NIa and CI
(a:CI and CI:a) and between NIb and CI (b:CI and CI:b). Also,
control strains expressing CI and GUS (CI:G and G:CI) were
tested. In both the plate and liquid culture-based assays, nei-
ther b-Gal activity nor His-independent growth were detected
in strains expressing any of these CI fusion combinations (Ta-
ble 1 and data not shown).
Domains involved in the NIa-NIb interaction. To identify
regions or domains within NIb that are necessary for the NIa-
NIb interaction, a series of five pAS2-derived plasmids with
deletions collectively spanning the entire NIb sequence was
generated and introduced into yeast cells known to contain
active NIa fusion protein, resulting in strains a:bD1, a:bD2,
a:bD3, a:bD4, and a:bD5 (Table 2). The proteins encoded by
the bD1 and bD5 mutants contained deletions of either the
N-terminal 141 or C-terminal 100 residues, respectively. These
sequences represent the least conserved regions in comparison
with other RNA polymerases encoded by picornavirus-like su-
pergroup members (30). The bD2, bD3, and bD4 mutant pro-
teins lacked the regions containing or immediately flanking the
highly conserved polymerase core region (30, 31). No b-Gal
activity above background and poor or no growth in SC-His
were detected with these strains (Table 2 and Fig. 6). In the
strains containing bD1, bD2, bD3, and bD4, the lack of inter-
action with NIa was not due to instability of the truncated
protein, as immunoblot analysis revealed that each strain ac-
cumulated an NIb-fusion protein to approximately the same
level as wild-type NIb (Fig. 7). In the strain containing the bD5
variant, however, no anti-NIb-reactive protein was detected
(data not shown). Using this deletion series, we were unable to
identify within NIb a functionally discrete domain for interac-
tion with NIa.
The VNN, EDE, and DD mutations were introduced into
the DB-NIb-encoding plasmid. The modified plasmids were
introduced into yeast cells expressing active ACT-NIa fusion
protein, resulting in the a:VNN, a:EDE, and a:DD strains.
b-Gal activity and growth in SC-His medium were high, or
even enhanced, in the a:EDE strain (Table 2 and Fig. 6). In
contrast, b-Gal activity and His-independent growth were rel-
atively low in the a:VNN strain and near background levels in
the a:DD strain. In multiple immunoblot experiments, one of
which is shown in Fig. 7, the relative signal intensities of wild-
type and mutant NIb fusion proteins were generally compara-
ble, indicating that the low interaction activity in the a:VNN
and a:DD strains was not due to low levels of fusion protein
accumulation. These data suggest that the GDD motif and the
NLS II sequence contribute either directly or indirectly to the
FIG. 4. b-Gal filter assay and plate-based His-independent growth assay of
yeast in the two-hybrid system. (A) Diagram of arrangement of yeast strains on
each set of plates. (B) b-Gal assay on nitrocellulose filters with the colorimetric
substrate X-Gal. (C) Growth of yeast on His-SC medium. Note that each yeast
strain that exhibited b-Gal activity also displayed His-independent growth.
FIG. 5. b-Gal and His-independent growth assays of yeast containing two-
hybrid combinations of NIa, NIb, and control proteins. The results of quantita-
tive b-Gal (nanomoles of o-nitrophenol per minute per milligram of total pro-
tein) assays using extracts from liquid cultures (A) and growth (OD600) in SC-His
medium (B) are shown. Three independently transformed yeast strains contain-
ing most two-hybrid combinations were tested and plotted on each graph. The
codes for each protein fused to GAL4 ACT and DB are as follows: a, NIa; b,
NIb; G, GUS; S1, SNF1; S4, SNF4; v, no protein fused to either ACT or DB.
Strains with a Da or Db designation were depleted of the plasmid encoding the
DB fusion protein, and then retransformed with a plasmid encoding the same or
a different DB fusion protein.










interaction between NIa and NIb, but that the NLS I region is
dispensable for the interaction.
To determine whether the VPg or Pro domain of NIa is
involved in the NIa-NIb interaction, two-hybrid combinations
with VPg (residues 1 to 188) and Pro (residues 189 to 430)
fusions were tested. Each yeast strain with VPg and Pro fusion
constructs was shown by PCR analysis to contain plasmid DNA
with an intact insert. However, immunoblot analysis with NIa
polyclonal antibody (44), or with VPg or Pro domain mono-
clonal antibodies (51), revealed that each protein accumulated
to either very low or nondetectable levels. The ACT-VPg fu-
sion was expressed in combination with DB fusions containing
NIb (VPg:b), NIa (VPg:a), the VPg (VPg:VPg), or Pro (VPg:
Pro) domains, CI (VPg:CI), or a negative control (VPg:GUS).
None of the strains containing combinations involving the VPg
domain yielded b-Gal activity or grew in SC-His medium (Ta-
ble 2 and data not shown). Similar results were obtained when
each reciprocal combination involving DB-VPg was tested (Ta-
ble 2 and data not shown).
In contrast, the Pro domain clearly interacted with NIb. The
Pro:b and b:Pro strains yielded moderate levels of b-Gal ac-
tivity and grew well in SC-His medium (Table 2 and Fig. 8),
although b-Gal and His-independent growth activities were
lower than with a:b strains. Importantly, the effects of the NIb
EDE, VNN, and DD mutations on the Pro-NIb interaction
were similar to those measured with the a:b combination. The
EDE mutation had no debilitating effects on b-Gal activity or
His-independent growth, whereas the VNN and DD mutations
dramatically reduced or eliminated both reporter activities
(Fig. 8). No evidence of an interaction was observed with
fusion combinations involving the Pro domain and NIa (Pro:a),
the VPg (Pro:VPg) or Pro (Pro:Pro) domains, CI (Pro:CI), or
negative controls (Table 2 and Fig. 8). These results strongly
suggest that the Pro domain is a primary determinant within
NIa involved in the NIa-NIb interaction.
FIG. 6. b-Gal and His-independent growth assays of yeast containing two-
hybrid combinations of NIa, wild-type, and mutant forms of NIb, and control
proteins. The results of quantitative b-Gal (nanomoles of o-nitrophenol per
minute per milligram of total protein) assays using extracts from liquid cultures
(A) and growth (OD600) in SC-His medium (B) are shown. Three independently
transformed yeast strains containing each two-hybrid combination were tested
and plotted on each graph, except for the a:bD1 strain in which only two trans-
formants were tested. The codes for each protein fused to GAL4 ACT and DB
are as follows: a, NIa; b, NIb; G, GUS; bD1, bD2, bD3, bD4, bD5, EDE, VNN, and
DD, mutant forms of NIb as described in the text; v, no protein fused to either
ACT or DB.
TABLE 2. Yeast strains, fusion combinations, and b-Gal filter assays
Yeast
strain ACT fusion
a DB fusion b-Gal filterassaya
a:bD1 NIa NIb, aa 1–141 deletedb 2
a:bD2 NIa NIb, aa 142–243 deleted 2
a:bD3 NIa NIb, aa 244–354 deleted 2
a:bD4 NIa NIb, aa 355–412 deleted 2
a:bD5 NIa NIb, aa 413–512 deleted 1/2
a:VNN NIa NIb, VNN mutation 1
a:EDE NIa NIb, EDE mutation 111
a:DD NIa NIb, DD mutation 2
VPg:b NIa VPg domain (aa 1–188) NIb 2
b:VPg NIb NIa VPg domain (aa 1–188) 2
Pro:b NIa Pro domain (aa 189–430) NIb 1
Pro:EDE NIa Pro domain (aa 189–430) NIb with EDE mutation 111
Pro:DD NIa Pro domain (aa 189–430) NIb with DD mutation 2
Pro:VNN NIa Pro domain (aa 189–430) NIb with VNN mutation 1
Pro:a NIa Pro domain (aa 189–430) NIa 2
Pro:VPg NIa Pro domain (aa 189–430) NIa VPg domain (aa 1–188) 2
Pro:Pro NIa Pro domain (aa 189–430) NIa Pro domain (aa 189–430) 2
Pro:CI NIa Pro domain (aa 189–430) CI 2
Pro:G NIa Pro domain (aa 189–430) GUS 2
Pro:v NIa Pro domain (aa 189–430) Vector 2
b:Pro NIb NIa Pro domain (aa 189–430) 1
a Colorimetric b-Gal filter assays were conducted by using at least three independent transformants of each yeast strain. Reactions were scored as follows: 2, no
visible reaction after overnight incubation;1/2, weak, inconsistent reaction that required development overnight;1, weak, but consistent, reaction that required several
hours’ or overnight development; 111, strong reaction that developed within minutes.
b aa, amino acid.











Nuclear transport signals of NIb. Our previous efforts to
define the NLS(s) within the full-length NIb were not success-
ful due to the high sensitivity of transport to sequence alter-
ations at numerous positions (37). However, two regions in
NIb, including residues 3 to 5 and 303 to 306, were suspected
previously to be possible NLSs based on their Arg- and Lys-
rich sequences. Substitutions of these residues within the GUS/
NIb fusion protein abolished nuclear translocation (37). In the
present study, NLS functions of the NIb 1 to 17 and 292 to 316
amino acid segments, which include the basic residues at po-
sitions 3 to 5 and 303 to 306, respectively, were demonstrated
when each segment was fused to the C terminus of GUS
independently from the remainder of NIb.
Although the 1 to 17 and 292 to 316 amino acid segments of
NIb by themselves function independently as NLSs, their ac-
tivities within NIb appear to depend heavily on the structural
integrity of the protein. Such structure-dependent NLS activity
has been detected in other systems. For example, although the
region containing the carboxyl-terminal 28 residues of herpes
simplex virus ICP8 contains an independent NLS, introduction
of modifications at other sites impedes nuclear translocation
(19). The susceptibility of translocation to structural modifica-
tions raises the possibility that control of NIb nuclear transport
might be achieved by conformational changes.
It should be stressed that although mutations affecting the
basic residues within the NLSs rendered TEV-GUS nonviable,
a requirement for NIb in the nucleus has not been demon-
strated. The sequences altered in the EDE and DD mutants
may be necessary for NIb functions other than nuclear trans-
location. The complementation data are consistent with this
idea. If the NIb variants encoded by these mutants were de-
fective only in nuclear translocation, they should have been
complemented to comparable levels in NIb1 cells. The fact
that the DD mutant was complemented to a level 21-fold
greater than the EDE mutant suggests that distinct functions
were affected by each mutation. Alternatively, the EDE and
DD mutations may have affected the same NIb replication
function, but the EDE mutant encoded a NIb protein with
dominant-negative properties that inhibited the complement-
ing activity of transgenic NIb.
Interaction between NIa and NIb. The finding that TEV
mutants containing replication-debilitating point mutations af-
fecting NIb, or lacking the NIb sequence altogether, could be
complemented in transgenic cells indicated that NIb is a trans-
active protein (36). A trans-active protein must be recruited to
active replication complexes by interactions with other repli-
cation factors or templates. Among the three TEV proteins
with known enzymatic functions in RNA replication, i.e., the
NIa, NIb, and CI proteins, an interaction was detected only
between NIa and NIb in the yeast two-hybrid system. Hong et
al. (26) have also demonstrated that NIa and NIb encoded by
the related potyvirus, tobacco vein mottling virus, physically
interact. Because deletions throughout the entire NIb mole-
cule abolished the NIa-NIb interaction, a specific interaction
domain within NIb was not identified. The interaction function
of NIb may depend on multiple regions within the NIb protein
FIG. 7. Immunoblot analysis of DB fusion proteins containing wild-type NIb
or mutant NIb derivatives from yeast. Two independently transformed yeast
strains containing each DB-NIb fusion protein and ACT-NIa fusion protein were
analyzed in parallel using equivalent amounts of extract. Blotted proteins were
reacted with an anti-NIb monoclonal antibody cocktail (51), and immunoreactive
proteins were detected by using a chemiluminescence system. (A) Extracts were
prepared from vector-transformed yeast (lane 1), or yeast expressing fusion
proteins containing wild-type NIb (lanes 2 and 3), EDE NIb mutant (lanes 4 and
5), VNN NIb mutant (lanes 6 and 7), and DD NIb mutant (lanes 8 and 9). The
EDE and DD mutant fusion proteins consistently migrated more slowly than the
wild-type fusion protein. (B) Extracts were prepared from yeast expressing the
bD1 (lanes 1 and 2), bD2 (lanes 4 and 5), bD3 (lanes 6 and 7), and bD4 (lanes 8
and 9) DB-NIb deletion variants and from vector-transformed yeast (lane 3). The
data shown in panels A and B were from two SDS-PAGE gels processed simul-
taneously with the same antibody concentration, incubation conditions, and
exposure times. Only the regions of the immunoblots showing the fusion proteins
are presented.
FIG. 8. b-Gal and His-independent growth assays of yeast containing two-
hybrid combinations with the Pro domain of NIa. The results of quantitative
b-Gal (nanomoles of o-nitrophenol per minute per milligram of total protein)
assays using extracts from liquid cultures (A) and growth (OD600) in SC-His
medium (B) are shown. Three independently transformed yeast strains contain-
ing each two-hybrid combination were tested and plotted on each graph, except
for the a:b, Pro:v, and v:v strains. The codes for each protein fused to GAL4 ACT
and DB are as follows: a, NIa; b, NIb; EDE, VNN, and DD, mutant forms of NIb
as described in the text; G, GUS; VPg, VPg domain of NIa; Pro, proteinase
domain of NIa; v, no protein fused to either ACT or DB.










or it may involve a stringent structural requirement throughout
the entire protein as has been suggested for the nuclear trans-
port function. This differs from protein-protein interactions of
some other positive-strand RNA virus polymerases. In the case
of brome mosaic virus 2a polymerase, an interaction with the
1a replication protein is mediated by a discrete N-terminal
domain (27, 28). Within NIa, however, the picornavirus 3C-
like Pro region was identified as an NIb-interacting domain.
Two lines of evidence support this conclusion. First, the Pro
domain alone interacted with NIb in the yeast system. And
second, the effects of three NIb clustered point mutations
(EDE, DD, and VNN) on the NIa-NIb and Pro-NIb interac-
tions were similar. While these data strongly implicate the Pro
domain as the interacting region within NIa, they do not ex-
clude a possible stabilizing or secondary effect of the VPg
domain on the interaction. Furthermore, although no interac-
tion between the VPg domain and NIb was detected, it is
possible that these proteins do interact in virus-infected cells
but that the yeast system was inadequate or insufficiently sen-
sitive. Failure to detect an interaction in the two-hybrid system
could be due to inactivation by GAL4 ACT or DB or to levels
of accumulation of fusion protein below a critical threshold, as
well as to an inherent inability of two proteins to interact.
Neither self-interaction of NIb nor interactions between the
CI helicase and either NIa or NIb were detected in the yeast
two-hybrid system. The lack of an observable self-interaction
of NIb is in contrast to the poliovirus 3Dpol. Active 3Dpol
functionally oligomerizes in vitro, prompting the conclusion
that it may act as a cooperative RNA-binding factor during
poliovirus RNA synthesis (41). The lack of detection of NIb
self-interaction may indicate functional differences between
the picornavirus and potyvirus polymerases. Alternatively, fail-
ure to detect NIb-NIb interaction may have been due to inter-
fering effects of the GAL4 domains in one or both fusion
proteins or to another suboptimal experimental condition. Sev-
eral possibilities of explaining the inability to detect interac-
tions involving the CI helicase, which is known to be required
for RNA replication (29), should be considered. The CI pro-
tein may not physically interact directly with either NIa or NIb.
The recruitment of CI protein to initiating or elongating rep-
lication complexes may involve interactions with RNA or with
proteins other than those analyzed here. The recruitment of CI
helicase to replication complexes might also be mediated
through interactions involving CI polyproteins, or other repli-
cation-associated polyproteins, none of which were tested. In
addition, failure to detect interactions might also have been
due to one or more of the limitations of the yeast two-hybrid
assay as discussed above.
The effects of EDE, DD, and VNN mutations on the NIa-
NIb interaction could explain some of the genetic properties of
the NIb polymerase. The VNN and DD mutations resulted in
NIb variants that interacted poorly with NIa, whereas the EDE
mutation had no inhibitory effect. In transgenic complementa-
tion experiments with mutant TEV-GUS genomes, the VNN
and DD mutants were rescued relatively efficiently by NIb in
trans, whereas the EDE mutant was rescued poorly. This dif-
ference could have been due to an interfering effect of the
defective NIb encoded by the EDE mutant. The EDE variant
protein may interact tightly with NIa in infected transgenic
cells, thus excluding access by functional NIb. The DD and
VNN mutant proteins, on the other hand, may be incapable of
interacting with NIa and, therefore, might not interfere with
the complementing activity of the transgenic protein. In this
sense, the EDE protein may display the properties of a dom-
inant-negative molecule. If the complementation data are ex-
plained by interference effects of the mutant NIb molecules,
then such a result may indicate that NIa-NIb interaction rep-
resents an important step in the TEVRNA replication process.
This hypothesis could be tested further by analyzing the effects
of additional NIb mutations on genome replication, comple-
mentation, and protein-protein interaction with NIa.
How might the interactions described here relate to repli-
cation of the TEV genome? The NIb polymerase may be
recruited to initiation complexes through protein-protein in-
teractions with the Pro domain of intact NIa (Fig. 9). The NIa
protein itself may be anchored to membranes in the form of a
6K/NIa polyprotein, or a larger polyprotein containing 6K/NIa,
as proposed previously (45, 46). How an NIa-NIb complex
might be associated with viral RNA or with other replication
proteins is not yet known. Initiation of RNA synthesis may be
stimulated by a priming mechanism involving the VPg domain
of NIa, as proposed for picornaviruses (22, 52, 53). Interest-
ingly, the proposed involvement of an NIa-NIb complex in
potyviral replication bears functional similarity to the involve-
ment of the 3Cpro-3Dpol polyprotein (3CD) in picornaviral
RNA synthesis. Biochemical and genetic evidence support a
model in which 3CD, in association with the 3AB VPg precur-
sor polyprotein, binds specifically to an “open” double-
stranded RNA template during positive-strand RNA synthesis
(3, 4, 24, 39, 42, 54, 55). Internal proteolytic cleavage by 3CD
releases 3D to catalyze RNA synthesis (39). In effect, the
potyviral and picornaviral models converge on the recruitment
of active polymerase through interaction with the 3C or 3C-like
(NIa) Pro domain; in picornaviruses this interaction is medi-
ated through a covalent bond within a polyprotein, while in the
potyviruses this interaction is through noncovalent protein-
protein contacts.
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